{"hands_on_practices": [{"introduction": "Accurate risk stratification in Congenital Diaphragmatic Hernia (CDH) begins with quantitative assessment of fetal lung size. This exercise focuses on calculating the raw Lung-to-Head Ratio (LHR), an early and foundational metric, requiring careful attention to units and measurement conventions. By engaging with this fundamental calculation, you will also critically explore its inherent limitations, which are crucial for understanding the evolution toward more sophisticated prognostic tools used in modern fetal medicine [@problem_id:4441521].", "problem": "A fetus with left-sided congenital diaphragmatic hernia (CDH) is being evaluated for eligibility for Fetoscopic Endoluminal Tracheal Occlusion (FETO). In a standardized four-chamber cardiac view, the contralateral (right) lung appears approximately elliptical, and the measured area is reported as $2.0\\,\\text{cm}^{2}$. The contemporaneous head circumference (HC), measured on the standard transthalamic plane, is $22\\,\\text{cm}$. Using the clinically accepted ultrasound-based definition of Lung-to-Head Ratio (LHR) employed for preoperative risk stratification in CDH prior to fetoscopic intervention, compute the numerical value of LHR for this examination. Express the final LHR in millimeters and round your answer to four significant figures. Then, based on first principles and well-tested clinical measurement concepts, critically discuss two fundamental limitations of interpreting unadjusted LHR (without observed-to-expected normalization, where observed-to-expected (O/E) denotes observed-to-expected scaling to gestational-age norms) when deciding on FETO candidacy.", "solution": "The problem presented is valid. It is scientifically grounded in the principles of fetal medicine and obstetrics, specifically concerning the prenatal risk stratification of congenital diaphragmatic hernia (CDH). The provided data are clinically realistic, and the question is well-posed, requiring a specific calculation based on a standard clinical definition and a critical discussion of its limitations.\n\nThe problem consists of two parts. First, to compute the Lung-to-Head Ratio (LHR) from given ultrasound measurements. Second, to discuss two fundamental limitations of interpreting this unadjusted LHR.\n\n**Part 1: Calculation of Lung-to-Head Ratio (LHR)**\n\nThe clinically accepted definition for the ultrasound-based Lung-to-Head Ratio (LHR) is the ratio of the contralateral lung area to the head circumference. The formula is:\n$$\nLHR = \\frac{\\text{Contralateral Lung Area}}{\\text{Head Circumference}}\n$$\nA critical aspect of this calculation is the consistent use of units. The standard clinical convention for this formula requires the lung area to be in square millimeters ($mm^2$) and the head circumference to be in millimeters ($mm$). The resulting LHR value will therefore have units of millimeters ($mm$).\n\nThe given values from the problem statement are:\n1.  Contralateral (right) lung area, $A_{lung} = 2.0 \\, \\text{cm}^2$.\n2.  Head circumference, $HC = 22 \\, \\text{cm}$.\n\nFirst, we must convert these measurements into the standard units required for the LHR formula. The conversion factors are:\n-   $1 \\, \\text{cm} = 10 \\, \\text{mm}$\n-   $1 \\, \\text{cm}^2 = (10 \\, \\text{mm})^2 = 100 \\, \\text{mm}^2$\n\nApplying these conversions to the given data:\nThe head circumference ($HC$) in millimeters is:\n$$\nHC = 22 \\, \\text{cm} \\times \\frac{10 \\, \\text{mm}}{1 \\, \\text{cm}} = 220 \\, \\text{mm}\n$$\nThe contralateral lung area ($A_{lung}$) in square millimeters is:\n$$\nA_{lung} = 2.0 \\, \\text{cm}^2 \\times \\frac{100 \\, \\text{mm}^2}{1 \\, \\text{cm}^2} = 200 \\, \\text{mm}^2\n$$\nNow, we can substitute these converted values into the LHR formula:\n$$\nLHR = \\frac{A_{lung}}{HC} = \\frac{200 \\, \\text{mm}^2}{220 \\, \\text{mm}}\n$$\nSimplifying the fraction:\n$$\nLHR = \\frac{20}{22} \\, \\text{mm} = \\frac{10}{11} \\, \\text{mm}\n$$\nTo obtain the numerical value, we perform the division:\n$$\nLHR \\approx 0.909090... \\, \\text{mm}\n$$\nThe problem requires the answer to be rounded to four significant figures.\n$$\nLHR \\approx 0.9091 \\, \\text{mm}\n$$\n\n**Part 2: Discussion of Fundamental Limitations of Unadjusted LHR**\n\nThe use of an unadjusted, or raw, LHR value for clinical decision-making, such as determining candidacy for FETO, has significant and well-documented limitations. The problem asks for a critical discussion of two such limitations, particularly in the context of not using gestational age-based normalization (i.e., observed-to-expected LHR).\n\n**1. Gestational Age Dependency:**\nThe most critical flaw of the unadjusted LHR is its strong dependence on gestational age. Both fetal lung area and head circumference increase throughout gestation, but they do so at different rates. The LHR is not a constant value; it naturally increases as the fetus matures. For instance, an LHR of $1.0$ at $24$ weeks gestation has a much graver prognosis than the same LHR of $1.0$ at $32$ weeks gestation. At the earlier gestation, the lung is significantly smaller than expected, whereas at the later gestation, it may be closer to the normal size for that age. Consequently, a single cutoff value for unadjusted LHR (e.g., $LHR  1.0$) cannot be applied uniformly across the gestational window during which FETO is considered (typically $26-30$ weeks). This confounding effect of gestational age compromises the prognostic accuracy and consistency of the raw LHR. This limitation was the primary motivation for developing the observed-to-expected LHR (O/E LHR), which normalizes the measured LHR against a reference mean value for that specific gestational age ($O/E \\, LHR = \\frac{\\text{Observed LHR}}{\\text{Expected LHR for GA}} \\times 100\\%$). The O/E LHR provides a more stable, gestational age-independent predictor of postnatal survival and morbidity.\n\n**2. Measurement Technique and Inter-observer Variability:**\nThe LHR value is highly susceptible to variations in ultrasound measurement technique and operator experience, which introduces significant potential for error and misclassification of risk. This limitation arises from two sources:\n-   **Lung Area Measurement:** The contralateral lung in a fetus with severe CDH is often compressed by the herniated abdominal organs and mediastinal shift. Its shape is frequently irregular, not the idealized ellipse mentioned in the problem. The area is typically measured by manually tracing the lung perimeter. This manual tracing is subjective and prone to significant inter-observer and intra-observer variability. A small change in the traced boundary can lead to a large percentage error in the calculated area, especially for the very small lungs seen in severe CDH. This directly impacts the numerator of the LHR, making the final value highly dependent on the operator's skill and interpretation.\n-   **Head Circumference Measurement:** While the measurement of head circumference is more standardized, it is not immune to error. The measurement must be taken in a precise axial plane—the transthalamic view—that includes specific anatomical landmarks. An oblique or off-axis plane will result in an erroneously large measurement of the head circumference. Since the HC is the denominator in the LHR calculation, an artificially inflated HC will lead to an artificially low LHR, which could wrongly place a fetus in a higher-risk category and potentially lead to an unnecessary recommendation for an invasive procedure like FETO.\nThese measurement issues underscore that a single LHR value should be interpreted with extreme caution, as it may not be a robust or reproducible metric without strict adherence to standardized protocols and ideally, confirmation of the measurement.", "answer": "$$\n\\boxed{0.9091}\n$$", "id": "4441521"}, {"introduction": "To address the significant limitation of gestational-age dependency inherent in the raw LHR, the concept of normalization is critical. This practice centers on calculating the Observed-to-Expected Lung-to-Head Ratio (O/E LHR), the current standard for prognosticating in CDH. Mastering this calculation is essential, as it transforms a variable measurement into a stable, comparable metric that underpins severity classification and eligibility for interventions like FETO [@problem_id:4441457].", "problem": "A fetal medicine team is counseling parents regarding potential candidacy for Fetoscopic Endoluminal Tracheal Occlusion (FETO) in a case of left-sided Congenital Diaphragmatic Hernia (CDH). A sonographic assessment at gestational age $26$ weeks yields an observed Lung-to-Head Ratio (LHR) of $1.2$. The gestation-matched expected LHR for a healthy fetus at $26$ weeks is $2.4$. The observed-to-expected normalization for LHR (O/E LHR) is defined as the ratio of the observed value to the gestation-matched expected value. Clinically, for left-sided CDH severity stratification based solely on O/E LHR, use the following thresholds for this problem: severe if $O/E LHR  0.25$, moderate if $0.25 \\leq O/E LHR  0.35$, mild if $0.35 \\leq O/E LHR  0.45$, and mild (favorable) if $O/E LHR \\geq 0.45$.\n\nUsing only the core definition that normalization relative to an expected value is computed as the ratio of the observed measurement to its corresponding expected value at the same gestational age, compute the O/E LHR from the data above and determine the severity category for left CDH using the provided thresholds. Express the O/E LHR as a dimensionless decimal fraction and round your numerical result to four significant figures. Do not use a percentage sign in your answer.", "solution": "We are given an observed Lung-to-Head Ratio (LHR) at gestational age $26$ weeks, $L_{\\mathrm{obs}} = 1.2$, and the expected LHR at the same gestational age, $L_{\\mathrm{exp}} = 2.4$. The observed-to-expected normalization for LHR (O/E LHR) is defined by the core normalization principle as the ratio of the observed to expected value:\n$$\nR \\equiv \\frac{L_{\\mathrm{obs}}}{L_{\\mathrm{exp}}}.\n$$\nSubstituting the given values,\n$$\nR = \\frac{1.2}{2.4} = 0.5.\n$$\nRounding $0.5$ to four significant figures gives $0.5000$.\n\nNext, we classify severity for left-sided Congenital Diaphragmatic Hernia (CDH) using the provided thresholds based solely on O/E LHR. The calculated $R = 0.5000$ satisfies $R \\geq 0.45$, which falls into the category designated as mild (favorable).\n\nTherefore, the computed O/E LHR is $0.5000$ (dimensionless, expressed as a decimal fraction), and the severity classification is mild (favorable). The requested numerical result to report is the O/E LHR value rounded to four significant figures.", "answer": "$$\\boxed{0.5000}$$", "id": "4441457"}, {"introduction": "Clinical expertise extends beyond individual calculations to the synthesis of multiple data points into a robust decision-making framework. This final practice challenges you to evaluate and select a complete clinical algorithm for offering FETO, integrating key variables such as O/E LHR, liver position, gestational timing, and maternal safety contraindications. By analyzing these decision trees, you will develop a systems-level understanding of how evidence-based principles are operationalized in high-stakes fetal therapy [@problem_id:4441530].", "problem": "You are asked to select a decision tree that operationalizes the offer of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in isolated left-sided Congenital Diaphragmatic Hernia (CDH) by mapping four inputs—gestational age, Observed-to-Expected Lung-to-Head Ratio (O/E LHR), liver position, and maternal comorbidities—onto a binary output: offer or do not offer FETO. Base your selection on first principles: the O/E LHR as a quantitative correlate of pulmonary hypoplasia severity, the prognostic impact of intrathoracic liver herniation at a given O/E LHR, the risk-benefit interplay of FETO including iatrogenic preterm birth risk that depends on timing of tracheal occlusion, and the primacy of maternal safety such that serious maternal comorbidities constitute contraindications to fetoscopy. Do not assume any effect modifiers beyond these four inputs, and assume singletons with otherwise isolated left-sided CDH.\n\nFour candidate decision trees are proposed. Each tree, when applied, must produce a binary decision for each fetus. Choose the single tree that most closely adheres to the evidence-based benefit-risk framework implied by these principles and correctly classifies all index fetuses below.\n\nIndex fetuses for adjudication:\n- Fetus X: gestational age $28.5$ weeks; O/E LHR $22\\%$; intrathoracic liver present; no maternal comorbidities.\n- Fetus Y: gestational age $30.2$ weeks; O/E LHR $38\\%$; intrathoracic liver absent; no maternal comorbidities.\n- Fetus Z: gestational age $29.0$ weeks; O/E LHR $33\\%$; intrathoracic liver present; complete placenta previa.\n- Fetus W: gestational age $29.5$ weeks; O/E LHR $42\\%$; intrathoracic liver present; no maternal comorbidities.\n\nDecision tree options:\n\nA. Decision tree with severity- and timing-stratified offers and strict maternal safety screen:\n- Step $1$: If any major maternal contraindication to fetoscopy is present (for example, complete placenta previa, clinically significant coagulopathy, or severe cardiopulmonary disease), do not offer FETO.\n- Step $2$: If gestational age is in 27.0–29.9 weeks and severe left-sided CDH is present, defined as either $O/E LHR  25\\%$ regardless of liver position, or $25\\% \\le O/E LHR  35\\%$ with intrathoracic liver, then offer FETO.\n- Step $3$: Else, if gestational age is in 30.0–31.9 weeks and moderate left-sided CDH is present, defined as either $25\\% \\le O/E LHR  35\\%$ without intrathoracic liver, or $35\\% \\le O/E LHR  45\\%$ regardless of liver position, then offer FETO.\n- Step $4$: Else, do not offer FETO.\n\nB. Decision tree that treats severity and timing broadly and ignores maternal comorbidities:\n- Offer FETO for any fetus with $O/E LHR  45\\%$ at gestational age 26.0–34.0 weeks, regardless of liver position or maternal comorbidities; otherwise do not offer.\n\nC. Decision tree that requires intrathoracic liver and earlier timing without maternal safety screen:\n- Offer FETO only if intrathoracic liver is present, $O/E LHR  35\\%$, and gestational age 24.0–29.9 weeks; otherwise do not offer. Maternal comorbidities do not alter the decision.\n\nD. Decision tree that restricts to the most extreme severity, narrows timing, and uses a limited safety screen:\n- Offer FETO only if $O/E LHR  25\\%$ and intrathoracic liver is present at gestational age 27.0–28.0 weeks; otherwise do not offer. Contraindications include only active systemic infection or fever; placenta previa is not a contraindication.\n\nWhich decision tree should be implemented to align with the stated principles and to correctly classify all four index fetuses?\nA. Tree A\nB. Tree B\nC. Tree C\nD. Tree D", "solution": "### Step 1: Extract Givens\n\nThe problem asks to select the best of four decision trees for offering Fetoscopic Endoluminal Tracheal Occlusion (FETO) for isolated left-sided Congenital Diaphragmatic Hernia (CDH).\n\n**Inputs for the decision tree:**\n1.  Gestational age\n2.  Observed-to-Expected Lung-to-Head Ratio (O/E LHR)\n3.  Liver position (intrathoracic or not)\n4.  Maternal comorbidities\n\n**Output of the decision tree:**\nA binary decision: offer FETO or do not offer FETO.\n\n**Context:**\nThe population is singleton pregnancies with otherwise isolated left-sided CDH.\n\n**Underlying Principles:**\n1.  The O/E LHR is a quantitative correlate of pulmonary hypoplasia severity. Lower O/E LHR implies more severe hypoplasia.\n2.  Intrathoracic liver herniation worsens the prognosis for a given O/E LHR.\n3.  The decision to offer FETO involves a risk-benefit analysis, particularly concerning iatrogenic preterm birth, which is influenced by the timing of the tracheal occlusion procedure.\n4.  Maternal safety is of primary importance; serious maternal comorbidities are contraindications to fetoscopy.\n\n**Index Fetuses for Adjudication:**\n-   **Fetus X:** Gestational age $28.5$ weeks; O/E LHR $22\\%$; intrathoracic liver present; no maternal comorbidities.\n-   **Fetus Y:** Gestational age $30.2$ weeks; O/E LHR $38\\%$; intrathoracic liver absent; no maternal comorbidities.\n-   **Fetus Z:** Gestational age $29.0$ weeks; O/E LHR $33\\%$; intrathoracic liver present; complete placenta previa.\n-   **Fetus W:** Gestational age $29.5$ weeks; O/E LHR $42\\%$; intrathoracic liver present; no maternal comorbidities.\n\n### Step 2: Validate Using Extracted Givens\n\nThe problem statement is evaluated against the criteria for validity.\n\n-   **Scientifically Grounded:** The problem is firmly rooted in maternal-fetal medicine, a subspecialty of obstetrics and gynecology. FETO for severe CDH is a real, evidence-based intervention. The prognostic factors listed (O/E LHR, liver position, gestational age) and the risk considerations (preterm birth, maternal safety) are central to clinical decision-making and are extensively documented in medical literature, notably the TOTAL trial (Tracheal Occlusion To Accelerate Lung growth). The problem is factually and scientifically sound.\n-   **Well-Posed:** The task is to select the best algorithm from a set of four candidates, based on its alignment with a set of explicit principles and its ability to correctly classify four well-defined test cases. This is a clear, solvable problem of evaluation and selection.\n-   **Objective:** The language is precise and unbiased. The principles are standard clinical axioms in this field. The index cases are defined by objective, quantitative data. The decision trees are specified algorithmically.\n\n### Step 3: Verdict and Action\n\nThe problem is valid. It is a well-constructed, scientifically grounded question that requires the application of established clinical principles to evaluate competing management algorithms. The solution process may proceed.\n\n### Derivation of the Correct Decision Tree\n\nTo select the best decision tree, we must first establish the correct decision for each index fetus based on the provided first principles.\n\n**Interpretation of First Principles:**\n1.  **Severity Assessment (Principles 1  2):** Severity increases with decreasing O/E LHR and the presence of an intrathoracic liver. Clinical evidence stratifies CDH roughly as:\n    -   Severe: $O/E LHR  25\\%$, or O/E LHR in the $25-35\\%$ range with an intrathoracic liver.\n    -   Moderate: O/E LHR in the $25-35\\%$ range without an intrathoracic liver, or O/E LHR in the $35-45\\%$ range.\n    -   Mild: O/E LHR $ > 45\\%$.\n2.  **Timing and Risk-Benefit (Principle 3):** The benefit of fetal lung growth requires time between balloon placement and delivery. The risk of iatrogenic prematurity suggests avoiding the procedure too late. Evidence supports a stratified approach: FETO is typically offered at 27.0-29.9 weeks for severe CDH and at 30.0-31.9 weeks for moderate CDH.\n3.  **Maternal Safety (Principle 4):** Maternal safety is paramount. Any condition that makes invasive fetal surgery unacceptably risky is an absolute contraindication. Complete placenta previa is a classic example, as uterine entry risks catastrophic maternal hemorrhage. Therefore, a maternal safety check should be the first step in any decision algorithm.\n\n**Application to Index Fetuses:**\n-   **Fetus X:** GA $28.5$ wks, O/E LHR $22\\%$, liver-up, no comorbidities. This represents severe CDH ($O/E LHR  25\\%$). The GA is within the appropriate window (27.0-29.9 weeks) for intervention in severe cases. There are no maternal contraindications. **Expected Decision: Offer FETO.**\n-   **Fetus Y:** GA $30.2$ wks, O/E LHR $38\\%$, liver-down, no comorbidities. This represents moderate CDH (O/E LHR in $35-45\\%$ range). The GA is within the appropriate window (30.0-31.9 weeks) for intervention in moderate cases. There are no maternal contraindications. **Expected Decision: Offer FETO.**\n-   **Fetus Z:** GA $29.0$ wks, O/E LHR $33\\%$, liver-up, complete placenta previa. This fetus has severe CDH criteria (O/E LHR $25-35\\%$ with liver-up) and is at an appropriate GA for intervention. However, the presence of complete placenta previa is an absolute contraindication to fetoscopy due to the high risk of life-threatening maternal hemorrhage. **Expected Decision: Do Not Offer FETO.**\n-   **Fetus W:** GA $29.5$ wks, O/E LHR $42\\%$, liver-up, no comorbidities. This represents moderate CDH (O/E LHR in $35-45\\%$ range). However, the GA of $29.5$ weeks is outside (too early for) the typical window for moderate CDH intervention (30.0-31.9 weeks). Offering FETO at this stage for this degree of severity is not aligned with the risk-benefit principle. **Expected Decision: Do Not Offer FETO.**\n\n**Summary of Expected Classifications:**\n-   Fetus X: Offer\n-   Fetus Y: Offer\n-   Fetus Z: Do Not Offer\n-   Fetus W: Do Not Offer\n\n### Option-by-Option Analysis\n\nWe now evaluate each proposed decision tree.\n\n**A. Decision tree with severity- and timing-stratified offers and strict maternal safety screen:**\n-   **Step 1:** Screens for major maternal contraindications first. This correctly identifies Fetus Z (complete placenta previa) and classifies it as **Do Not Offer FETO**. This aligns with Principle 4.\n-   **Step 2:** Offers FETO for severe CDH at GA 27.0–29.9 weeks.\n    -   Fetus X (GA $28.5$, O/E LHR $22\\%$) meets the criterion $O/E LHR  25\\%$. The tree correctly classifies it as **Offer FETO**.\n-   **Step 3:** Offers FETO for moderate CDH at GA 30.0–31.9 weeks.\n    -   Fetus Y (GA $30.2$, O/E LHR $38\\%$) meets the criterion $35\\% \\le O/E LHR  45\\%$. The tree correctly classifies it as **Offer FETO**.\n-   **Step 4:** For all other cases, do not offer FETO.\n    -   Fetus W (GA $29.5$, O/E LHR $42\\%$) does not meet the criteria for Step 2 (O/E LHR is too high) or Step 3 (GA is too early). It thus falls to Step 4 and is classified as **Do Not Offer FETO**. This is the correct decision.\n-   **Verdict:** This tree perfectly aligns with all stated principles, including the primacy of maternal safety, severity stratification using both O/E LHR and liver position, and a risk-adapted, timed intervention strategy. It correctly classifies all four index fetuses. **Correct.**\n\n**B. Decision tree that treats severity and timing broadly and ignores maternal comorbidities:**\n-   This tree's rule is: Offer if $O/E LHR  45\\%$ and GA is 26.0–34.0 weeks.\n-   It violates Principle 4 by ignoring maternal comorbidities. It would incorrectly offer FETO to Fetus Z, risking maternal life.\n-   It violates Principle 2 by ignoring liver position.\n-   It violates the nuance of Principle 3 by using one broad, unstratified time window.\n-   Classification:\n    -   Fetus X: O/E LHR is $22\\% ( 45\\%)$, GA $28.5$ in range $\\implies$ Offer. (Correct decision, flawed logic).\n    -   Fetus Y: O/E LHR is $38\\% ( 45\\%)$, GA $30.2$ in range $\\implies$ Offer. (Correct decision, flawed logic).\n    -   Fetus Z: O/E LHR is $33\\% ( 45\\%)$, GA $29.0$ in range $\\implies$ Offer. (Incorrect; ignores contraindication).\n    -   Fetus W: O/E LHR is $42\\% ( 45\\%)$, GA $29.5$ in range $\\implies$ Offer. (Incorrect; offers for moderate CDH outside appropriate window).\n-   **Verdict:** This tree is grossly oversimplified, clinically unsafe, and makes two incorrect classifications. **Incorrect.**\n\n**C. Decision tree that requires intrathoracic liver and earlier timing without maternal safety screen:**\n-   This tree's rule is: Offer if liver-up, $O/E LHR  35\\%$, and GA is 24.0–29.9 weeks.\n-   It violates Principle 4 by not having a maternal safety screen. It would incorrectly offer FETO to Fetus Z.\n-   It violates Principle 3 by not having a pathway for moderate CDH at a later gestation.\n-   Classification:\n    -   Fetus X: Liver-up, O/E LHR is $22\\% ( 35\\%)$, GA $28.5$ in range $\\implies$ Offer. (Correct decision).\n    -   Fetus Y: Liver is not intrathoracic $\\implies$ Do Not Offer. (Incorrect; standard protocols offer FETO for this category).\n    -   Fetus Z: Meets all criteria $\\implies$ Offer. (Incorrect; ignores contraindication).\n    -   Fetus W: The O/E LHR of $42\\%$ is not $35\\% \\implies$ Do Not Offer. (Correct decision).\n-   **Verdict:** This tree fails to account for maternal safety and misses a key group of candidates for FETO (moderate CDH), leading to two incorrect classifications. **Incorrect.**\n\n**D. Decision tree that restricts to the most extreme severity, narrows timing, and uses a limited safety screen:**\n-   This tree's rule is: Offer if $O/E LHR  25\\%$, liver-up, GA 27.0–28.0 weeks.\n-   It violates Principle 4 by having an inadequate safety screen that explicitly ignores placenta previa. It would offer FETO to a fetus with these parameters and placenta previa.\n-   It violates the nuance of Principle 3 by using an overly restrictive timing window (27.0–28.0 weeks instead of 27.0-29.9) and by completely excluding moderate CDH candidates.\n-   Classification:\n    -   Fetus X: GA $28.5$ weeks is outside the 27.0–28.0 week window $\\implies$ Do Not Offer. (Incorrect; this is a prime candidate for FETO).\n    -   Fetus Y: The O/E LHR is not $25\\% \\implies$ Do Not Offer. (Incorrect; fails to offer to a valid moderate CDH candidate).\n    -   Fetus Z: The O/E LHR is not $25\\% \\implies$ Do Not Offer. (Correct decision, but for the wrong reason; the tree would not have stopped for the placenta previa).\n    -   Fetus W: The O/E LHR is not $25\\% \\implies$ Do Not Offer. (Correct decision).\n-   **Verdict:** This tree is overly restrictive, uses an incorrect safety screen, and makes two incorrect classifications based on flawed criteria. **Incorrect.**\n\nBased on the analysis, Decision Tree A is the only option that correctly incorporates all stated first principles and correctly classifies all four index cases.", "answer": "$$\\boxed{A}$$", "id": "4441530"}]}